Skip to main content
Best News Website or Mobile Service
 
WAN-IFRA Digital Media Awards Worldwide
Best News Website or Mobile Service
 
Digital Media Awards Worldwide
Hamburger Menu

Advertisement

Advertisement

World

WHO panel backs use of Omicron-adapted vaccine as booster dose

WHO panel backs use of Omicron-adapted vaccine as booster dose

FILE PHOTO: A logo is pictured at the World Health Organization (WHO) building in Geneva, Switzerland, February 2, 2020. REUTERS/Denis Balibouse

A modified COVID-19 vaccine that targets the Omicron variant can be administered as a booster dose to broaden immunity, a technical advisory group set up the World Health Organization said on Friday (Jun 17).

Such a variant-adapted vaccine may benefit those who have already received the primary series of shots, the agency's panel on COVID-19 Vaccine Composition said, citing available data.

The vaccines could be considered for use globally by the agency once they get emergency use authorisation or an approval by a stringent national regulatory authority.

Vaccine makers including Moderna and Pfizer are developing a potential next generation booster targeted at both the Omicron variant as well as the original strain of the coronavirus.

Moderna last week said a new version of its vaccine produced a better immune response against Omicron than the original shot, while the European Medicines Agency this week began rolling reviews of the variant-adapted COVID-19 vaccines from Moderna and Pfizer.

BOOKMARK THIS: Our comprehensive coverage of the COVID-19 pandemic and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus pandemic: https://cna.asia/telegram

Source: Reuters

Advertisement

Also worth reading

Advertisement